WASHINGTON – A Maryland biomedical research company said Tuesday that the Food and Drug Administration has cleared the way for human trials to begin on an HIV vaccine it helped develop
List of Dialysis Centers With High Mortality Rates Includes Many in Maryland
WASHINGTON – Nearly 10 percent of U
When Pounds Equal Dollars: Obesity Forces Hospitals to Upgrade Equipment
WASHINGTON – The national obesity epidemic is not just hard on patients’ hearts — it’s hard on hospitals’ hardware, too
State Officials Say Hospital Took Too Long to Warn of Faulty HIV Tests
WASHIGTON – State Health Secretary Nelson Sabatini said Thursday that Maryland General Hospital took too long to notify people that HIV and hepatitis-C tests done at the hospital over a 14-month period could have yielded false results
Elder Marylanders Take a Walk on the Healthful Side
HANOVER – Doug Dale, 68, has walked nearly 3,000 miles without leaving Arundel Mills Mall
Maryland Victim Worried by Senate Bill to Curb Asbestos Payouts
WASHINGTON – Ellen Patton grew up helping her dad with projects around the family’s house in Arnold — projects that Patton now says exposed her to asbestos products that caused her to develop mesothelioma
Judge Says First Amendment Trumps Ficker’s Claim on Campaign Web Site Name
WASHINGTON – A federal judge Thursday denied Republican congressional candidate Robin Ficker’s claim on the domain name “robinficker
Ficker Files Suit to Reclaim Name From Web Site in Campaign Dust-Up
WASHINGTON – Congressional candidate Robin Ficker has sued the owner of robinficker
NIH May Grant Rockville Firm Exclusive Rights on West Nile Vaccine
WASHINGTON – The National Institutes of Health may grant a Rockville-based company the exclusive right to produce a human vaccine that the agency is developing for the West Nile virus
FluMist Flop Has MedImmune Thinking Twice About Staying in Vaccine Business
WASHINGTON – The research chief of Gaithersburg-based MedImmune told a House committee Thursday that the company may get out of the vaccine-production business, following disappointing sales of its nasal-spray vaccine this flu season